Tag Archives | ADC antibody-drug conjugates

Rayno Life Science Stocks: Up 30%+ YTD After A Volatile October

Investors Whipsawed By V-Shaped Rally NASDAQ at New Highs 4631 DOW at New Highs 17,390 Investors got what was forecasted-a volatile October that moved from fear to greed in two weeks! The market was buffeted by the Ebola scare, macro analysts decrying easy money from the FED and a potential global economic slowdown. But fears […]

Continue Reading

Rayno Life Science Performance: Up 21%+ YTD…FBT, GILD, ILMN

Biotechs Continue To Lead The Market NASDAQ registered its third day of gains up 2.38% for the period and life science stocks followed. The NAZ is now up 3.34% YTD. Biotech stocks are way ahead of the market  YTD with our top ETF pick (FBT) up 31% YTD and 3.66% over five days.The IBB is […]

Continue Reading

Rayno Life Sciences: First Half Stock Performance Part I-ACHN, AMRI, VRTX

Biopharmaceutical Stocks Come Roaring Back After Q1 Correction Most Stocks Bottomed in April -We are Currently in Rally Mode The biotech sector is up 18% YTD as tracked by most popular ETFs (FBT,IBB,XBI). After a vicious sell-off from the February bubble the biotech sector bottomed in April and has climbed slowly t within 5% of  Q1 […]

Continue Reading

Biotech Recap On a Down Day

NASDAQ Off 0.8%  On Disappointing Economic Data and Spiking Crude  Islamic militants took major cities in Iraq  causing a spike in oil to $106. The energy sector rallied 0.7% with many smaller players soaring over 4%. The energy sector is very strong up 10% YTD. Retails sales rose less than expected with a 0.3% increase […]

Continue Reading

Risk Appetite Returns To Biotech With IBB Up Over 3%

Rayno Life Science Stocks -Green Screen Rules-NASDAQ (4168) Up 1.16% Speculative ETF XBI (134.50) up 4.69% and 7.88% over 5 days; 52 week high $172.52. ETF PBE ($40.85)  up over 3%. Momentum stocks are soaring but way off all time highs in February. Big Rayno Biopharma Movers: ACHN up 8%, ALKS up 3.4%, ARIA up […]

Continue Reading